Kairos Pharma, Ltd.
KAPANYSEAMERICANHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $14.36M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.43$3.51
- Volume (live)
- -
- Avg. volume (3M)
- 673.05K
Kairos Pharma (KAPA) Stock Price & Financial Analysis
Kairos Pharma Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.66 - $0.72 |
|---|---|
| 52-Week High | $3.51 |
| 52-Week Low | $0.43 |
| Open | $0.72 |
| Volume (last close) | 253.33K |
| Average Volume (3M) | 673.05K |
| 50-Day MA | $1.77 |
|---|---|
| 200-Day MA | $1.35 |
| 1-Year Change | −42.19% |
| Market Cap | 14.36M |
|---|---|
| Shares Outstanding | 21.42M |
| Price to Book (P/B) | 3.43 |
| EV/EBITDA | -2.05 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Kairos Pharma at a Glance
As of the Oct 15, 2026 close, Kairos Pharma (KAPA) has a market capitalization of $14.36M.
As of its latest reported balance sheet, it holds $2.63M in cash and securities against $0.00 of debt, a net cash position of $2.63M.
Kairos Pharma does not currently pay a dividend.
The share price is down 42.2% over the past year. At $0.67 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.43 to $3.51, below its 200-day moving average of $1.35.
Frequently Asked Questions About Kairos Pharma
What is the current stock price for KAPA?
As of the Oct 15, 2026 close, KAPA stock trades at $0.67. The 52-week range is $0.43–$3.51, with a day range of $0.66–$0.71.
What is the P/E ratio for KAPA?
The P/E ratio (Price-to-Earnings) for KAPA is shown in the Key Statistics section. This valuation metric helps compare Kairos Pharma, Ltd. to industry peers.
Does KAPA pay dividends?
Kairos Pharma does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for KAPA?
Analyst ratings and recommendations for KAPA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of KAPA?
As of the Oct 15, 2026 close, Kairos Pharma's market capitalization is $14.4M, classifying it as a micro-cap company. Kairos Pharma operates in the Healthcare sector within the Biotechnology industry.